Cognoa Announces Poster Presentations at the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition Oct 6, 2022
Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal StudySep 23, 2020
Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicinesSep 10, 2019
Healthcare Industry Still Lacks Inclusivity And Accessibility: These 7 Female Leaders Are Here To Change ThatMar 27, 2022
Cognoa to Present and Exhibit at the 2021 American Academy of Pediatrics (AAP) National Conference and ExhibitionOct 8, 2021